KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Goodwill: 2022-2025

Historic Goodwill for Castle Biosciences (CSTL) over the last 4 years, with Sep 2025 value amounting to $10.7 million.

  • Castle Biosciences' Goodwill changed negligibly% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $10.7 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Goodwill is $10.7 million, which was down 0.00% from $10.7 million recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Goodwill registered a high of $10.7 million during Q4 2022, and its lowest value of $10.5 million during Q3 2022.
  • In the last 3 years, Castle Biosciences' Goodwill had a median value of $10.7 million in 2025 and averaged $10.7 million.
  • Data for Castle Biosciences' Goodwill shows a peak YoY increased of 2.04% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Castle Biosciences' Goodwill stood at $10.7 million in 2022, then remained steady at $10.7 million in 2023, then remained steady at $10.7 million in 2024, then remained steady at $10.7 million in 2025.
  • Its last three reported values are $10.7 million in Q3 2025, $10.7 million for Q2 2025, and $10.7 million during Q1 2025.